Medical Selection of Life Risks
Description:
Medical Selection of Life Risks has long been recognised as the reference book on insurance medicine. The fourth edition provides a comprehensive guide to life expectancy for underwriters and clinicians involved in the life insurance industry. Extensively revised and expanded the 4th edition of Medical Selection of Life Risks reflects developments in life and healthcare insurance as well as medicine. There are completely new chapters: on the underwriting of genetic diseases, disability underwriting, impaired lives annuities, musculoskeletal and soft tissue disorders. Several major chapters have been completely re-written, including respiratory, ischemic and congenital heart diseases and oncology. Part I - deals with the principles of life and disability insurance and the logistics of life underwriting. Part II - is devoted to a systematic clinical appraisal of underwriting problems, mainly relating to life insurance but also, where appropriate, to disability, critical illness and long term care insurance.
Best prices to buy, sell, or rent ISBN 9781561591961
Frequently Asked Questions about Medical Selection of Life Risks
You can buy the Medical Selection of Life Risks book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $448.21 on Amazon and is available from 1 sellers at the moment.
If you’re interested in selling back the Medical Selection of Life Risks book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Medical Selection of Life Risks book, the best buyback offer comes from and is $ for the book in good condition.
The Medical Selection of Life Risks book is in very low demand now as the rank for the book is 10,186,331 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.